Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bispecific antibodies as bridging to BCMA CAR-T cell therapy for relapsed/refractory multiple myeloma.
Fandrei D, Seiffert S, Rade M, Rieprecht S, Gagelmann N, Born P, Wiemers T, Weidner H, Kreuz M, Schassberger T, Kossmann J, Mangold M, Furst D, Fischer L, Baber R, Heyn S, Wang SY, Bach E, Hoffmann S, Metzeler KH, Herlling M, Jentzsch M, Franke GN, Kohl U, Friedrich M, Boldt A, Reiche K, Platzbecker U, Vucinic V, Merz M. Fandrei D, et al. Among authors: gagelmann n. Blood Cancer Discov. 2024 Oct 23. doi: 10.1158/2643-3230.BCD-24-0118. Online ahead of print. Blood Cancer Discov. 2024. PMID: 39441177
Sequential Conditioning With FLAMSA Does Not Improve Outcomes of Allogeneic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia Patients.
Massoud R, Klyuchnikov E, Steiner N, Zeck G, Heidenreich S, Langebrake C, Niederwieser C, Rathje K, Gagelmann N, Janson D, Wolschke C, Ayuk F, Kröger N. Massoud R, et al. Among authors: gagelmann n. Transplant Cell Ther. 2024 Oct 16:S2666-6367(24)00696-1. doi: 10.1016/j.jtct.2024.10.003. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39419178 Free article.
Navigating 'grey areas' and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMT.
Polverelli N, Hernández-Boluda JC, Gagelmann N, Gurnari C, Malagola M, Duarte FB, Funke VAM, Zerbi C, McLornan DP. Polverelli N, et al. Among authors: gagelmann n. Bone Marrow Transplant. 2024 Oct 14. doi: 10.1038/s41409-024-02437-6. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39402189 Review.
Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete Remission.
Steiner N, Massoud R, Richter J, Perekhrestenko T, Gagelmann N, Niederwieser C, Rathje K, Lastovytska I, Schäfersküpper M, Heidenreich S, Rudolph I, Zeck G, Janson D, Wolschke C, Ayuk FA, Klyuchnikov E, Kröger N. Steiner N, et al. Among authors: gagelmann n. Eur J Haematol. 2024 Sep 19. doi: 10.1111/ejh.14305. Online ahead of print. Eur J Haematol. 2024. PMID: 39300830
Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell Transplantation.
Gagelmann N, Schuh C, Zeiser R, Stelljes M, Bethge W, Wulf G, Teschner D, Klein S, Wagner-Drouet E, Jost E, Dreger P, Flossdorf S, Kröger N. Gagelmann N, et al. Transplant Cell Ther. 2024 Oct;30(10):1011.e1-1011.e13. doi: 10.1016/j.jtct.2024.07.026. Epub 2024 Aug 3. Transplant Cell Ther. 2024. PMID: 39102984 Free article.
Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages: an EU COST Action cGvHD Eurograft project.
Gjærde LK, Brück O, Gagelmann N, Gavriilaki E, Inngjerdingen M, Keranen M, Kisch A, Myhre AE, Olivieri A, Perez-Simon JA, Perovic D, Perovic V, Piekarska A, Pulanic D, Rathje K, Van Veen S, Dachy G, Moiseev I, Penack O, Peric Z, Greinix H, Lee SJ, Wolff D, Schoemans H. Gjærde LK, et al. Among authors: gagelmann n. Bone Marrow Transplant. 2024 Oct;59(10):1477-1479. doi: 10.1038/s41409-024-02374-4. Epub 2024 Jul 17. Bone Marrow Transplant. 2024. PMID: 39020019 No abstract available.
Reply to Z. Yin et al.
Gagelmann N, Merz M. Gagelmann N, et al. J Clin Oncol. 2024 Sep 1;42(25):3064. doi: 10.1200/JCO.24.00863. Epub 2024 Jun 24. J Clin Oncol. 2024. PMID: 38913972 No abstract available.
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation.
Steiner N, Massoud R, Klyuchnikov E, Gagelmann N, Richter J, Niederwieser C, Rathje K, Urbanowicz T, Kunte A, Engelmann J, Ihne C, Lastovytska I, Lindhauer C, Marquard F, Reichard M, Ryzhkova A, Sabauri R, Schäfersküpper M, Seyedi N, Kalogeropoulos G, Heidenreich S, Rudolph I, Zeck G, Janson D, Wolschke C, Ayuk F, Kröger N. Steiner N, et al. Among authors: gagelmann n. Bone Marrow Transplant. 2024 Sep;59(9):1265-1274. doi: 10.1038/s41409-024-02328-w. Epub 2024 Jun 14. Bone Marrow Transplant. 2024. PMID: 38877098 Free PMC article.
78 results